Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Lone gene could force re-think on pest insect control

09.07.2003


Scientists have discovered a single gene that gives the vinegar fly resistance to a range of pesticides, including DDT, but warn it could spell disaster if found in pest insect species.



The geneticists from the University of Melbourne fear that should this mutation arise in pest insects, the world will need to rethink its overall control strategies.

The researchers are part of the Centre for Environmental Stress and Adaptation Research (CESAR) a special research centre that includes researchers from the Universities of Melbourne, La Trobe and Monash. They will present their findings as a series of posters at the International Congress of Genetics on Monday 7 July.


The discovery of a single mutation in one gene has provided the fly (Drosophila sp) with resistance to a range of commonly available, but chemically unrelated, pesticides.

What has baffled and worried the researchers is that the flies are rarely targeted with insecticides and many of the chemicals it is resistant to, it has never been exposed to before.

“The fact that a single mutation can confer resistance to the banned insecticide DDT and a range of unrelated pesticides, even to those the species has never encountered, reveals new risks and costs to the chemical control of pest insects,” says Michael Bogwitz, one of the poster authors.

“This research shows how easy it is for a single mutation to have such a diverse impact. A similar mutation in a pest species could have devastating consequences,” he says.

“Unless we reassess our current methods of pest management, our future options for control may become severely restricted.”

Their research suggests the mutation arose in Drosophila soon after the introduction of DDT and has since spread throughout the world. But unlike a normal mutation, this one persisted rather than disappeared as the use of DDT around the world declined.

Mutations normally only persist if there is selective pressures from the environment that give individuals with the mutation an advantage over the rest of the population. When that pressure is removed, for instance the banning of DDT, individuals with the mutation are usually less fit and selected against, with fitter individuals replacing them.

“Having the mutation does not appear to affect the fitness of individuals. This could add to the problem of controlling pest species should the gene be found in these species as well,” says Bogwitz.

“This highlights more than ever that what we do today to control pests could irreversibly change the gene pool of that species,” he says.

The culprit – Cyp6g1
The Drosophila gene causing all the concern is called Cyp6g1. It is part of a large family of genes called the Cytochrome P450 genes that are found in many species, including humans.

Previous studies have implicated some members of this P450 family in pesticide resistance. However the function of the majority of the 90 Drosophila P450 genes is unknown.

CESAR researchers are now analysing these genes to determine their function in Drosophila and in the pest insects, the cotton bollworm (Helicoverpa armigera) and the sheep blowfly responsible for flystrike (Lucilia cuprina).

“Our capacity to control pests would be significantly improved if we understood the defence mechanisms controlled by these genes,” says Trent Perry, member of the poster team.

In the Drosophila, Cyp6g1 confers resistance by producing up to 100 times more than the normal level of protein that breaks down DDT and other pesticides. Given the number of P450 genes present in Drosophila, it was unexpected that a single version of one gene could be associated with such widespread resistance, and that this resistance also applied to a wide range of compounds that bear no resemblance to each other in structure or mode of function. These compounds include organochlorines, organophosphorous, carbamate and insect growth regulator insecticides.

“Our research, so far, does not unequivocally demonstrate that Cyp6g1 is the sole culprit for this resistance, but the current evidence leaves little doubt that about its central role,” says Perry.

Bogwitz and Perry’s posters cover their latest research into the resistance qualities of Cyp6g1 and also provide insight to secondary mechanisms of resistance that may be operating.

The primary research was done by Dr Phil Daborn in the laboratory of Professor Richard ffrench-Constant at the University of Bath. Dr Daborn started the initial work as a PhD student under Dr Phillip Batterham and Professor John McKenzie at the University of Melbourne and is about to start post-doctoral studies in Batterham and McKenzie’s lab. Other collaborators on the poster include Dr Batterham, Dr David Heckel.

Jason Major | University of Melbourne
Further information:
http://uninews.unimelb.edu.au/view.php?articleID=748

More articles from Life Sciences:

nachricht Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology

nachricht Mapping immune cells in brain tumors
29.05.2020 | University of Zurich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>